Literature DB >> 2156170

Sequence-specific artificial photo-induced endonucleases based on triple helix-forming oligonucleotides.

L Perrouault1, U Asseline, C Rivalle, N T Thuong, E Bisagni, C Giovannangeli, T Le Doan, C Hélène.   

Abstract

Homopyrimidine oligonucleotides bind to homopurine-homopyrimidine sequences of duplex DNA forming a local triple helix. This binding can be demonstrated either directly by a footprinting technique, gel assays, or indirectly by inducing irreversible reactions in the target sequence, such as photocrosslinking or cleavage. Binding occurs in the major groove with the homopyrimidine oligonucleotide orientated parallel to the homopurine strand. Thymine and protonated cytosine in the oligonucleotide form Hoogsteen-type hydrogen bonds with A.T and G.C Watson-Crick base pairs, respectively. Here we report that an 11-residue homopyrimidine oligonucleotide covalently attached to an ellipticine derivative by its 3' phosphate photo-induces cleavage of the two strands of a target homopurine--homopyrimidine sequence. To our knowledge, this is the first reported case of a sequence-specific artificial photoendonuclease. In addition we show that a strong binding site for a free ellipticine derivative is induced at the junction between the triplex and duplex structures on the 5' side of the bound oligonucleotide. On irradiation, cleavage is observed on both strands of DNA. This opens new possibilities for inducing irreversible reactions on DNA at specific sites by the synergistic action of a triple helix-forming oligonucleotide and an intercalating agent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156170     DOI: 10.1038/344358a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  35 in total

1.  Drug binding to higher ordered DNA structures: netropsin complexation with a nucleic acid triple helix.

Authors:  Y W Park; K J Breslauer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

2.  Thermodynamics of triple helix formation: spectrophotometric studies on the d(A)10.2d(T)10 and d(C+3T4C+3).d(G3A4G3).d(C3T4C3) triple helices.

Authors:  D S Pilch; R Brousseau; R H Shafer
Journal:  Nucleic Acids Res       Date:  1990-10-11       Impact factor: 16.971

3.  Sequence-specific photo-induced cross-linking of the two strands of double-helical DNA by a psoralen covalently linked to a triple helix-forming oligonucleotide.

Authors:  M Takasugi; A Guendouz; M Chassignol; J L Decout; J Lhomme; N T Thuong; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

4.  Photofootprinting of DNA triplexes.

Authors:  V I Lyamichev; O N Voloshin; M D Frank-Kamenetskii; V N Soyfer
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

5.  Sequence-dependent cleavage of DNA by alkylation with antisense oligodeoxyribonucleotides containing a 2-(N-iodoacetylaminoethyl)thio-adenine.

Authors:  K Kido; H Inoue; E Ohtsuka
Journal:  Nucleic Acids Res       Date:  1992-03-25       Impact factor: 16.971

6.  Uranyl photofootprinting of triple helical DNA.

Authors:  P E Nielsen
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

Review 7.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 8.  Repair of DNA lesions associated with triplex-forming oligonucleotides.

Authors:  Joanna Y Chin; Peter M Glazer
Journal:  Mol Carcinog       Date:  2009-04       Impact factor: 4.784

9.  Cleavage of double-stranded DNA by 'metalloporphyrin-linker-oligonucleotide' molecules: influence of the linker.

Authors:  P Bigey; G Pratviel; B Meunier
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

10.  PCNA damage caused by antineoplastic drugs.

Authors:  Soo In Bae; Ran Zhao; Robert M Snapka
Journal:  Biochem Pharmacol       Date:  2008-09-06       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.